MBX - Company ID 0001776111
The table below shows MBX Biosciences, Inc.'s income statement line items across its last 3 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Revenue | - | - | - |
| Cost of revenue | - | - | - |
| Gross profit | - | - | - |
| R&D | $79.16M | $57.41M | $28.53M |
| SG&A | $18.90M | $10.78M | $6.78M |
| Operating income | -$98.06M | -$68.19M | -$35.31M |
| Income tax | $0.00 | $0.00 | $0.00 |
| Net income |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$87.00M |
| -$61.92M |
| -$32.56M |
| EPS (diluted) | -$2.38 | -$5.82 | -$31.96 |